J. Reilly

813 total citations
23 papers, 521 citations indexed

About

J. Reilly is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. Reilly has authored 23 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J. Reilly's work include Schizophrenia research and treatment (10 papers), Personality Disorders and Psychopathology (6 papers) and Bipolar Disorder and Treatment (5 papers). J. Reilly is often cited by papers focused on Schizophrenia research and treatment (10 papers), Personality Disorders and Psychopathology (6 papers) and Bipolar Disorder and Treatment (5 papers). J. Reilly collaborates with scholars based in United Kingdom, Australia and Netherlands. J. Reilly's co-authors include I. Nicol Ferrier, Shl Thomas, Salma Ayis, Angela Hill, Charles S. Cornford, Judy Bradley, Mike Crawford, J.S. Elborn, John Main and Jay Saoud and has published in prestigious journals such as American Journal of Psychiatry, Cochrane Database of Systematic Reviews and Social Science & Medicine.

In The Last Decade

J. Reilly

23 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Reilly United Kingdom 11 211 157 78 71 59 23 521
Mary Weber United States 11 387 1.8× 131 0.8× 45 0.6× 34 0.5× 27 0.5× 28 789
Guido Di Sciascio Italy 16 282 1.3× 245 1.6× 27 0.3× 33 0.5× 19 0.3× 35 630
Joel J. Silverman United States 12 157 0.7× 135 0.9× 31 0.4× 38 0.5× 23 0.4× 34 502
S. K. Mattoo India 15 165 0.8× 176 1.1× 33 0.4× 11 0.2× 53 0.9× 46 642
Karen R. Reeves United States 10 414 2.0× 256 1.6× 282 3.6× 156 2.2× 50 0.8× 19 1.1k
F Casadebaig France 9 370 1.8× 125 0.8× 19 0.2× 27 0.4× 98 1.7× 23 505
Gregorio Cerminara Italy 8 231 1.1× 90 0.6× 27 0.3× 29 0.4× 14 0.2× 11 393
Ola Granström Sweden 8 474 2.2× 190 1.2× 36 0.5× 15 0.2× 84 1.4× 13 722
Ricardo F. Muñoz United States 10 68 0.3× 164 1.0× 224 2.9× 18 0.3× 18 0.3× 14 944
Eleanor Feldman United States 13 220 1.0× 124 0.8× 25 0.3× 26 0.4× 25 0.4× 20 528

Countries citing papers authored by J. Reilly

Since Specialization
Citations

This map shows the geographic impact of J. Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Reilly more than expected).

Fields of papers citing papers by J. Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Reilly. The network helps show where J. Reilly may publish in the future.

Co-authorship network of co-authors of J. Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of J. Reilly. A scholar is included among the top collaborators of J. Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Reilly. J. Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crawford, Mike, Lavanya Thana, Rachel Evans, et al.. (2020). Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT. Health Technology Assessment. 24(44). 1–54. 8 indexed citations
2.
Feltz‐Cornelis, Christina M. van der, Sally Brabyn, Sarah Allen, et al.. (2020). Conversion and neuro-inflammation disorder observational study (CANDO). Protocol of a feasibility study. The European Journal of Psychiatry. 34(3). 164–172. 3 indexed citations
3.
Crawford, Mike, Rahil Sanatinia, Barbara Barrett, et al.. (2018). Lamotrigine for people with borderline personality disorder: a RCT. Health Technology Assessment. 22(17). 1–68. 16 indexed citations
4.
Crawford, Mike, Rahil Sanatinia, Barbara Barrett, et al.. (2018). The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial. American Journal of Psychiatry. 175(8). 756–764. 49 indexed citations
5.
McMurran, Mary, J. Reilly, Paul McCrone, et al.. (2017). Psychoeducation and Problem Solving (PEPS) Therapy for Adults With Personality Disorder: A Pragmatic Randomized-Controlled Trial. Journal of Personality Disorders. 31(6). 810–826. 8 indexed citations
6.
Davidson, Michael, Jay Saoud, Corinne Staner, et al.. (2017). Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. American Journal of Psychiatry. 174(12). 1195–1202. 74 indexed citations
7.
Crawford, Mike, Rahil Sanatinia, Barbara Barrett, et al.. (2015). Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation. Trials. 16(1). 308–308. 9 indexed citations
8.
Crawford, Mike, et al.. (2014). Are mood stabilisers helpful in treatment of borderline personality disorder?. BMJ. 349(sep16 3). g5378–g5378. 6 indexed citations
9.
Curtis, Sarah, Wilbert M. Gesler, Victoria Wood, et al.. (2013). Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards. Social Science & Medicine. 97. 201–209. 42 indexed citations
10.
Zyl, Martin van, et al.. (2013). Awareness of venous thromboembolism in mental health services for older people. Journal of Psychiatric and Mental Health Nursing. 21(4). 375–378. 3 indexed citations
11.
McMurran, Mary, Mike Crawford, J. Reilly, et al.. (2011). Psycho-education with problem solving (PEPS) therapy for adults with personality disorder: A pragmatic multi-site community-based randomised clinical trial. Trials. 12(1). 198–198. 12 indexed citations
12.
Niens, Ulrike & J. Reilly. (2011). Global Dimension in the Northern Ireland Curriculum: school approaches, teaching and learning. Research Portal (Queen's University Belfast). 1 indexed citations
13.
Reilly, J., et al.. (2009). Lithium and chronic kidney disease. BMJ. 339(jul03 1). b2452–b2452. 32 indexed citations
14.
Cornford, Charles S., Angela Hill, & J. Reilly. (2007). How patients with depressive symptoms view their condition: a qualitative study. Family Practice. 24(4). 358–364. 57 indexed citations
15.
Thanacoody, Ruben, Ann K. Daly, J. Reilly, I. Nicol Ferrier, & Simon H. L. Thomas. (2007). Factors Affecting Drug Concentrations and QT Interval During Thioridazine Therapy. Clinical Pharmacology & Therapeutics. 82(5). 555–565. 27 indexed citations
16.
Elborn, J.S., et al.. (2006). Self-management in bronchiectasis: the patients' perspective. European Respiratory Journal. 29(3). 541–547. 42 indexed citations
17.
Reilly, J., et al.. (2002). Thioridazine and sudden unexplained death in psychiatric in-patients. The British Journal of Psychiatry. 180(6). 515–522. 108 indexed citations
18.
Reilly, J., Sandra H. Thomas, & I. Nicol Ferrier. (2002). Recent studies on ECG changes, antipsychotic use and sudden death in psychiatric patients. Psychiatric Bulletin. 26(3). 110–112. 2 indexed citations
19.
Reilly, J., et al.. (2000). Thioridazine for schizophrenia. Cochrane Database of Systematic Reviews. CD001944–CD001944. 6 indexed citations
20.
Reilly, J. & John Kremer. (1999). A qualitative investigation of women's perceptions of premenstrual syndrome: implications for general practitioners.. PubMed. 49(447). 783–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Weber Breakdown of academic impact, for papers by Guido Di Sciascio Breakdown of academic impact, for papers by Joel J. Silverman Breakdown of academic impact, for papers by S. K. Mattoo Breakdown of academic impact, for papers by Karen R. Reeves Breakdown of academic impact, for papers by F Casadebaig Breakdown of academic impact, for papers by Gregorio Cerminara Breakdown of academic impact, for papers by Ola Granström Breakdown of academic impact, for papers by Ricardo F. Muñoz Breakdown of academic impact, for papers by Eleanor Feldman
Rankless by CCL
2026